RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

Osivax publishes phase 2a results of OVX836-004 study; supports co-administration of OVX836 with seasonal flu vaccine: Lyon, France Saturday, July 12, 2025, 18:00 Hrs [IST] Osivax ...

Co-administration of OVX836 with seasonal inactivated influenza vaccine (Fluarix® Tetra) was well-tolerated and demonstrated a favorable safety profileRobust complementary immune responses were ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

CSL Seqirus, a subsidiary of Australia’s CSL Limited, said it has commenced shipping its differentiated portfolio of ...

Flu cases are on the rise this season, as vaccination levels fall and COVID-style social distancing falls by the wayside.

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

The U.S. Centers for Disease Control and Prevention said on Monday it has ended its emergency response for H5N1 bird flu, ...

The CDC is ending its emergency response to bird flu, citing a significant drop in cases between February and July.

The Centers for Disease Control and Prevention ended its emergency response to bird flu as the outbreak that sickened dozens ...

Amid the sultry summer months, a few signs of fall become apparent, such as the appearance of school supplies on stores ...

Shares of GSK rose on Thursday after the company announced it had begun shipping its seasonal flu vaccines, Fluarix and ...